Verrica Pharmaceuticals' Series B - II Round

Verrica Pharmaceuticals raised a round of funding on February 21, 2018. Investors include PBM Capital Group.

Verrica Pharmaceuticals (NASDAQ: VRCA) is a pharmaceutical company developing proprietary topical therapies for the treatment of lesional skin diseases such as Verruca vulgaris (common warts and plant…

Articles about Verrica Pharmaceuticals' Series B - II Round: